Bio-Rad Laboratories, Inc.
BIO· NYSE
BIOBio-Rad Laboratories, Inc.
Filed Jul 31, 2025 · 10-Q · 31 days after period end · 0000012208-25-000052
| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|
| Revenue | $651.60M | $638.50M | $681.11M | $691.10M |
| Net Income | $317.80M | -$2.17B | -$1.16B | -$925.10M |
| EPS Diluted | $11.67 | -$76.26 | -$39.59 | -$31.05 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio-Rad Laboratories, Inc. · CIK 12208 · Engraved from SEC EDGAR
ended Jun 30, 2025 · filed Jul 31, 2025 · 31 d after period end
